• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ChemMedChem . Adamantyl Amines Activity Study Against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple blocker Explored wit

tetano

Editor, Senior Moderator
ChemMedChem


. 2023 Jun 28;e202300182.
doi: 10.1002/cmdc.202300182. Online ahead of print. Adamantyl Amines Activity Study Against Mutant Influenza A M2 Channels Identified a Polycyclic Cage Amine Triple blocker Explored with MD simulations and Solid state NMR

Anja Hoffman[SUP] 1 [/SUP], Marianna Stampolaki[SUP] 2 [/SUP], Christina Tzitzoglaki[SUP] 2 [/SUP], Patrick Schmerer[SUP] 1 [/SUP], Chunlong Ma[SUP] 3 [/SUP], Kristin Döring[SUP] 1 [/SUP], Andreea Turcu[SUP] 4 [/SUP], Jun Wang[SUP] 3 [/SUP], Santiago Vazquez[SUP] 4 [/SUP], Michaela Schmidtke[SUP] 1 [/SUP], Antonios Kolokouris[SUP] 5 [/SUP], Ioannis Stylianakis[SUP] 2 [/SUP], Kumar Tekwani Movellan[SUP] 6 [/SUP], Loren Andreas[SUP] 7 [/SUP], Stefan Becker[SUP] 8 [/SUP]



Affiliations
Abstract

We compared the anti-influenza potencies of 57 adamantyl amines and analogs against influenza A virus with serine-31 M2 proton channel, usually termed as WT M2 channel, which is amantadine sensitive. We also tested a sub-set of these compounds against viruses with the amantadine resistant L26F, V27A, A30T, G34E M2 mutant channels. (a) Four compounds inhibited WT M2 virus in vitro with mid-nanomolar and 27 compounds with sub-micromolar to low micromolar potency. (b) Several compounds inhibited L26F M2 virus in vitro with sub-micromolar to low micromolar potency, but only three compounds blocked by electrophysiology L26F M2-mediated proton current. (c) One compound was a triple blocker by EP of WT, L26F, V27A M2 channels but did not inhibit V27A M2 virus in vitro and one compound inhibited WT, L26F, V27A M2 in vitro without blocking V27A M2 channel. (d) One compound blocked only L26F M2 channel by electrophysiology but did not inhibit virus replication. (e) The triple blocker compound by electrophysiology is as long as rimantadine but could bind and block V27A M2 channel due to the compound's bigger girth as revealed by MD simulations while MAS NMR informed on the interaction of the compound with M2(18-60) WT or L26F or V27A.

Keywords: adamantyl amine; electrophysiology; molecular dynamics; mutant influenza A M2 proton channel; solid state NMR.

 
Back
Top Bottom